Furthermore, tamoxifen-mediated GPER activation impairs the conversion of pancreatic stellate cells into myofibroblasts (an equivalent of CAFs in pancreatic tumors), which in turn leads to reduced cancer cell survival (40, 41). The gene discussed is GPER1; the disease is pancreatic neoplasm.